Sub Cat. No. |
Molecular Weight |
Glycan Name |
Functional Group |
Inquiry |
X25-03-ZQ601-1 |
PEG 350 Da |
Xanthan |
Heparin |
Inquiry
|
X25-03-ZQ601-2 |
PEG 550 Da |
Xanthan |
Heparin |
Inquiry
|
X25-03-ZQ601-3 |
PEG 750 Da |
Xanthan |
Heparin |
Inquiry
|
X25-03-ZQ601-4 |
PEG 1 kDa |
Xanthan |
Heparin |
Inquiry
|
X25-03-ZQ601-5 |
PEG 2 kDa |
Xanthan |
Heparin |
Inquiry
|
X25-03-ZQ601-6 |
PEG 3 kDa |
Xanthan |
Heparin |
Inquiry
|
X25-03-ZQ601-7 |
PEG 4 kDa |
Xanthan |
Heparin |
Inquiry
|
X25-03-ZQ601-8 |
PEG 5 kDa |
Xanthan |
Heparin |
Inquiry
|
X25-03-ZQ601-9 |
PEG 10 kDa |
Xanthan |
Heparin |
Inquiry
|
X25-03-ZQ601-10 |
PEG 20 kDa |
Xanthan |
Heparin |
Inquiry
|
Properties
Description
This anticoagulant polysaccharide conjugate features heparin linked to the polysaccharide xanthan via a polyethylene glycol (PEG) spacer, potentially enabling studies on thromboembolism or the development of biocompatible coatings with antithrombotic properties.
Source
Chemical synthesis
Impurities
No visible impurities to the naked eye.
Solubility
Heparin-PEG-xanthan is soluble in a wide range of organic solvents, such as DCM, DMF, and DMSO, and shows excellent solubility in water.
Identity
Confirmed by NMR.
Stability
The product is stable for 1 year when stored at the recommended temperature in powder.
Quality Level
Research grade
Applications
Heparin-PEG-xanthan can be used to study interactions with heparin-binding proteins or as an anticoagulant model in non-clinical settings.
Storage
Store at -20°C, protect from light.